Impact of Trabectedin Interruption and Subsequent Rechallenge on Progression in Patients With Advanced Soft Tissue Sarcoma - Archive ouverte HAL Access content directly
Journal Articles American Journal of Clinical Oncology Year : 2018

Impact of Trabectedin Interruption and Subsequent Rechallenge on Progression in Patients With Advanced Soft Tissue Sarcoma

(1) , (2) , (3) , (4) , (5) , (6) , (7) , (2) , (8) , (7) , (7) , (9) , (10)
1
2
3
4
5
6
7
8
9
10
Not file

Dates and versions

hal-03623697 , version 1 (29-03-2022)

Identifiers

Cite

Nuria Kotecki, Axel Le Cesne, Emmanuelle Tresch-Bruneel, Isabelle Ray-Coquard, Christine Chevreau, et al.. Impact of Trabectedin Interruption and Subsequent Rechallenge on Progression in Patients With Advanced Soft Tissue Sarcoma. American Journal of Clinical Oncology, 2018, 41 (11), pp.1094-1100. ⟨10.1097/coc.0000000000000430⟩. ⟨hal-03623697⟩
13 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More